CHT102
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CHT102, covering 2024-12-04 to 2025-04-10. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer [Phase 1]